Sales rise 10.31% to Rs 140.61 crore
Net profit of Lincoln Pharmaceuticals rose 2.95% to Rs 23.71 crore in the quarter ended September 2022 as against Rs 23.03 crore during the previous quarter ended September 2021. Sales rose 10.31% to Rs 140.61 crore in the quarter ended September 2022 as against Rs 127.47 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales140.61127.47 10 OPM %20.5522.96 -PBDT34.4832.53 6 PBT32.0630.54 5 NP23.7123.03 3Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content